Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Fourth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Fourth Quarter Common Stock Distribution of $0.12 Per Share

TORONTO, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Sprott Focus Trust, Inc. (Nasdaq: FUND ) (the “Fund” or “FUND”) has declared a quarterly distribution of $0.12 per share on its Common Stock.  The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on December 28, 2016 to stockholders of record at the close of business on December 15, 2016 (ex-dividend on December 12, 2016).  The price of shares issued for reinvestment will be determined on December 21, 2016.

The Fund currently has adopted a Distribution Policy of paying quarterly distributions on its Common Stock.  Distributions are being made at the annual rate of 5% of the rolling average of the prior four calendar quarter-end net asset values (“NAVs”), with the fourth quarter distribution being the greater of 1.25% of the rolling average or the minimum distribution required by IRS regulations. The policy, including the annual rate, is subject to change at the discretion of the Fund’s Board of Directors.

The Fund’s estimated sources of the distribution to be paid on December 28, 2016 and for 2016 year-to-date are as follows:

Estimated Allocations as of November 30, 2016

  Distribution Per Share Net Investment Income Net Realized Short-Term Gains Net Realized Long-Term Gains Return of Capital
FUND $ 0.1200   $0.0125 (10%) $0.0000 (0%) $0.1075 (90%) $0.0000 (0%)

Estimated Allocations for 2016 through November 30, 2016

  Distribution Per Share Net Investment Income Net Realized Short-Term Gains Net Realized Long-Term Gains Return of Capital
FUND $ 0.4000   $0.1350 (34%) $0.0286 (7%) $0.2364 (59%) $0.0000 (0%)

You should not draw any conclusions about the Fund’s investment performance from the amount of the current distribution or from the terms of the Fund’s Distribution Policy.  The amounts and sources of distributions reported herein are only estimates and are not being provided for tax reporting purposes.  The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations.  The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Fund Performance and Distribution Rate Information:

  Average Annual Total Return (in relation to NAV for the 5-year period ending on 11/30/2016) 1 Annualized Current Distribution Rate (expressed as a percentage of NAV as of 11/30/2016) 2 Cumulative total return (in relation to NAV for the fiscal year through 11/30/2016) 3 Cumulative fiscal year Distribution Rate (as a percentage of NAV as of 11/30/2016) 4
FUND   6.95 %   5.97 %   22.19 %   4.98 %

1 Average Annual Total Return in relation to NAV represents the compound average of the Annual NAV Total Returns of the Fund for the five year period ended November 30, 2016.  Annual NAV Total Return is the percentage change in the Fund’s NAV over a year, assuming reinvestment of distributions paid.

2 The annualized Current Distribution Rate is the current fiscal period’s distribution rate annualized as a percentage of the Fund’s NAV as of November 30, 2016.

3 Cumulative Total Return is the percentage change in the Fund’s NAV from December 31, 2015 to November 30, 2016, assuming reinvestment of distributions paid.

4 The Cumulative Fiscal Year Distribution Rate is the dollar value of distributions for the fiscal year period (January 1, 2016 to December 30, 2016) as a percentage of the Fund’s NAV as of November 30, 2016.

About Sprott Focus Trust, Inc.

Sprott Focus Trust, Inc. is a closed-end diversified management investment company whose shares of Common Stock are listed and traded on the Nasdaq Global Select Market.  The Fund’s investment goal is long-term capital growth, which it seeks by normally investing at least 65% of its assets in equity securities.

For further information on the Fund, please visit our web site at: www.sprottfocustrust.com .

Royal Bank Plaza | 200 Bay Street | Toronto, Ontario | Canada M5J 2J1 | (416) 943-6707 | www.sprott.com

 

Contact: Glen Williams (416) 943-4394

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 214

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 0

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Power Generation System from Pipeline Flow Unveiled

Updated Category News Views 231

Revolutionizing Energy Generation from Pipelines Innovators are always seeking new ways to deliver sustainable energy solutions, and one recent idea has emerged that may change the way we think about power generation. An inventive thinker has designed a technology that utilizes pipelines, specifically those carrying fluid or gas, to generate electricity. This innovative...

Continue Reading
Elliott Hill Takes Helm at Nike: A Step Toward Retail Revival

Updated Category News Views 276

Elliott Hill Takes Charge at Nike Nike Inc. (NYSE: NKE) has appointed Elliott Hill as its new CEO. This decision aims to strengthen the brand's connections with retail partners and enhance sales efforts. What Led to the Change? Hill steps into this important role following the departure of John Donahoe, who implemented a direct-to-consumer sales model. While this approach...

Continue Reading
ImageneBio Completes Merger with Ikena Oncology and Raises Capital

Updated Category News Views 249

ImageneBio's New Era Begins with Merger and Funding Boost The merger between Inmagene Biopharmaceuticals and Ikena Oncology marks a significant milestone as the newly formed company, ImageneBio, Inc., is set to make its debut on Nasdaq with the ticker symbol ‘IMA’. This exciting transition underlines the commitment of ImageneBio to further develop innovative...

Continue Reading
Equity Lifestyle Properties: Insights Ahead of Earnings Report

Updated Category News Views 168

Equity Lifestyle Properties' Earnings Expectations Equity Lifestyle Properties (ELS) is preparing for an upcoming quarterly earnings announcement that is highly anticipated by investors. This release is set to provide crucial insights into the company's financial health and projections for future growth. Analyst Predictions for Earnings Experts in the field forecast that...

Continue Reading
NexPoint Advocates for UDF IV Shareholders Amid Acquisition Talks

Updated Category News Views 119

NexPoint Advocates for UDF IV Shareholders Amid Acquisition Talks NexPoint Real Estate Opportunities, LLC, along with its affiliates, has expressed its thoughts regarding the proposed acquisition of United Development Funding IV (UDF IV) by Ready Capital Corporation. This transaction highlights NexPoint's continued commitment to impacting shareholder value. Transaction...

Continue Reading